ConductScience.org, home

Paper7907677

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.

Lancet, 1994. Cited by 826 papers, by iCite.

Cite this record

ConductScience Library. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Papers, record 7907677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7907677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
PubMed
Journal
Lancet
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
826
iCite
Relative citation ratio, by iCite
25.7
iCite
Revised in PubMed
2022-03-17
PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AspirinMajor topic
Atrial FibrillationMajor topic
Cerebrovascular DisordersMajor topic
ThromboembolismMajor topic
WarfarinMajor topic
Aged
Aged, 80 and over
Follow-Up Studies
Humans
Risk Factors

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01-NS-24224NINDS NIH HHSUnited StatesR01NS024224PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00281073Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) StudyBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in7907673Aspirin or warfarin for non-rheumatic atrial fibrillation?https://conductscience.org/library/papers/7907673PubMed
Comment in7911211Stroke Prevention in Atrial Fibrillation II Study.https://conductscience.org/library/papers/7911211PubMed
Comment in7911213Stroke Prevention in Atrial Fibrillation II Study.https://conductscience.org/library/papers/7911213PubMed

Download CSV of comments and corrections

Cited by213

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 826 citations.

PMIDTitleJournalYearIn PapersSource
42253356Research Advances in Timing of Anticoagulant Therapy Following Cardioembolic Stroke.Clin Med Insights Cardiol2026https://conductscience.org/library/papers/42253356PubMed
41635420
Extensive Intracerebral Hemorrhage Involving Basal Ganglia and Frontal Lobe With Intraventricular and Subarachnoid Extension in a Triplet Pregnancy Following In Vitro Fertilization: A Case Report and Review.
Clin Case Rep2026https://conductscience.org/library/papers/41635420PubMed
41557516Effectiveness and Safety of Direct Oral Anticoagulants versus Aspirin in Patients with Non-Valvular Atrial Fibrillation and Intermediate Stroke Risk.Clin Appl Thromb Hemost2026https://conductscience.org/library/papers/41557516PubMed
41212662Association between first anticoagulant prescription and embolic and hemorrhagic events among older adults with atrial fibrillation.J Intern Med2026https://conductscience.org/library/papers/41212662PubMed
41181448Left atrial appendage closure versus anticoagulation in the management of atrial fibrillation: a systematic review, meta-analysis, and meta-regression analysis.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/41181448PubMed
40843856First-Ever Stroke Outcomes in Patients with Atrial Fibrillation: A Retrospective Cross-Sectional Study.Medicines (Basel)2025https://conductscience.org/library/papers/40843856PubMed
40630456Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines.Rev Cardiovasc Med2025https://conductscience.org/library/papers/40630456PubMed
39131471Left Atrial Appendage Occlusion: Current Stroke Prevention Strategies and a Shift Toward Data-Driven, Patient-Specific Approaches.J Soc Cardiovasc Angiogr Interv2022https://conductscience.org/library/papers/39131471PubMed
38813294Effectiveness of Anticoagulants in Reducing Stroke Risk Among Patients With Atrial Fibrillation.Cureus2024https://conductscience.org/library/papers/38813294PubMed
38525596Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.Circ Cardiovasc Qual Outcomes2024https://conductscience.org/library/papers/38525596PubMed
37887081Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry.Clin Pract2023https://conductscience.org/library/papers/37887081PubMed
37292062Persistence to rivaroxaban therapy for stroke prevention in clinical practice in Italy: Rationale and design of the RITMUS-AF prospective observational cohort study.Int J Cardiol Heart Vasc2023https://conductscience.org/library/papers/37292062PubMed
37119087Evaluation of Quantitative Decision-Making for Rhythm Management of Atrial Fibrillation Using Tabular Q-Learning.J Am Heart Assoc2023https://conductscience.org/library/papers/37119087PubMed
36670269Risk Factors for Anticoagulant-Associated Intracranial Hemorrhage: A Systematic Review and Meta-analysis.Neurocrit Care2023https://conductscience.org/library/papers/36670269PubMed
36342828Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway.J Am Heart Assoc2023https://conductscience.org/library/papers/36342828PubMed
35957664Application of fresh frozen plasma transfusion in the management of excessive warfarin-associated anticoagulation.Blood Sci2022https://conductscience.org/library/papers/35957664PubMed
35900898Antiplatelet agents and anticoagulants for hypertension.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/35900898PubMed
35420918Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions.Circ Res2022https://conductscience.org/library/papers/35420918PubMed
34874889Machine Learning Methodologies for Prediction of Rhythm-Control Strategy in Patients Diagnosed With Atrial Fibrillation: Observational, Retrospective, Case-Control Study.JMIR Med Inform2021https://conductscience.org/library/papers/34874889PubMed
34386117Atrial fibrillation in the elderly population: Challenges and management considerations.J Arrhythm2021https://conductscience.org/library/papers/34386117PubMed

See all 213 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Authors
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7907677

GET https://conductscience.org/api/papers/v1/7907677/cited_by?page=2